Coffee intake

Progress in Molecular Biology and Translational Science

Volumn 108, Issue , 2012, Pages 293-322

  Cornelis, Marilyn C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Caffeine; Cancer; Cardiovascular disease; Coffee; Dietary behavior; Gene environment interaction; Genome wide association; Parkinson's disease; Reproductive health; Single nucleotide polymorphism

Indexed keywords

EID: 84861806777     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-398397-8.00012-5     Document Type: Chapter

References (192)

1. International Coffee Organization. Annual review; 2009-2010
2. A. Rosso, J. Mossey, and C.F. Lippa Caffeine: neuroprotective functions in cognition and Alzheimer's disease Am J Alzheimers Dis Other Demen 23 2008 417 422
3. R.M. van Dam, and F.B. Hu Coffee consumption and risk of type 2 diabetes: a systematic review JAMA 294 2005 97 104
4. S. Cnattingius, L.B. Signorello, G. Anneren, B. Clausson, A. Ekbom, and E. Ljunger Caffeine intake and the risk of first-trimester spontaneous abortion N Engl J Med 343 2000 1839 1845
5. R.M. van Dam Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer Appl Physiol Nutr Metab 33 2008 1269 1283
6. M.C. Cornelis, and A. El-Sohemy Coffee, caffeine, and coronary heart disease Curr Opin Lipidol 18 2007 13 19
7. Z. Zhang, G. Hu, B. Caballero, L. Appel, and L. Chen Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies Am J Clin Nutr 93 2011 1212 1219
8. G.B. Schreiber, M. Robins, C.E. Maffeo, M.N. Masters, A.P. Bond, and D. Morganstein Confounders contributing to the reported association of coffee or caffeine with disease Prev Med 17 1988 295 309
9. A. D'Amicis, and R. Viani The consumption of coffee S. Garattini, Caffeine, coffee, and health 1993 Raven Press New York 1 16
10. A.H. Varnam, and J.P. Sutherland Beverages: technology, chemistry, and microbiology 1994 Chapman and Hall London
11. M.A. Spiller The chemical components of coffee G.A. Spiller, Caffeine 1998 CRC Boca Raton 97 161
12. R.M. Gilbert Caffeine consumption G.A. Spiller, The methylxanthine beverages and foods: chemistry, consumption, and health effects 1984 Alan R. Liss Inc New York 185 213
13. J.V. Higdon, and B. Frei Coffee and health: a review of recent human research Crit Rev Food Sci Nutr 46 2006 101 123
14. A. Scalbert, and G. Williamson Dietary intake and bioavailability of polyphenols J Nutr 130 2000 2073S 2085S
15. M.N. Clifford Chlorogenic acids and other cinnamates, nature, occurrence, dietary burden, absorption and metabolism J Sci Food Agric 80 2000 1033 1043
16. D. Hervert-Hernandez, and I. Goni Contribution of beverages to the intake of polyphenols and antioxidant capacity in obese women from rural Mexico Public Health Nutr 15 2012 6 12
17. L.C. Turgo, and R. Macrae A study of the effect of roasting on the chlorogenic acid composition of coffee using HPLC Food Chem 15 1984 219 227
18. P.S. Variyar, R. Ahmed, R. Bhat, Z. Niyas, and A. Sharma Flavoring components of raw monsooned arabica coffee and their changes during radiation processing J Agric Food Chem 51 2003 7945 7950
19. F. Natella, M. Nardini, I. Giannetti, C. Dattilo, and C. Scaccini Coffee drinking influences plasma antioxidant capacity in humans J Agric Food Chem 50 2002 6211 6216
20. D.V. Rodriguez de Sotillo, M. Hadley, and J.E. Sotillo Insulin receptor exon 11 +/- is expressed in Zucker (fa/fa) rats, and chlorogenic acid modifies their plasma insulin and liver protein and DNA J Nutr Biochem 17 2006 63 71
21. K.L. Johnston, M.N. Clifford, and L.M. Morgan Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine Am J Clin Nutr 78 2003 728 733
22. N.V. Chuyen Maillard reaction and food processing. Application aspects Adv Exp Med Biol 434 1998 213 235
23. M. Daglia, A. Papetti, C. Gregotti, F. Berte, and G. Gazzani In vitro antioxidant and ex vivo protective activities of green and roasted coffee J Agric Food Chem 48 2000 1449 1454
24. R.C. Borrelli, A. Visconti, C. Mennela, M. Anese, and V. Fogliano Chemical characterization and antioxidant properties of coffee melanoidins J Agric Food Chem 50 2002 6527 6533
25. K. Iwai, N. Kishimoto, Y. Kakino, K. Mochida, and T. Fujita In vitro antioxidative effects of tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans J Agric Food Chem 52 2004 4893 4898
26. Y. Kono, K. Kobayashi, S. Tagawa, K. Adachi, A. Ueda, and Y. Sawa Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen Biochem Biophys Acta 1335 1997 335 342
27. W.M. Mazur, K. Wahala, S. Rasku, A. Salakka, T. Hase, and H. Adlercreutz Lignan and isoflavonoid concentrations in tea and coffee Br J Nutr 79 1998 37 45
28. N. Pellegrini, M. Serafini, B. Colombi, D. Del Rio, S. Salvatore, and M. Bianchi Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays J Nutr 133 2003 2812 2819
29. K. Yanagimoto, H. Ochi, K.G. Lee, and T. Shibamoto Antioxidative activities of fractions obtained from brewed coffee J Agric Food Chem 52 2004 592 596
30. V. Fogliano, and F.J. Morales Estimation of dietary intake of melanoidins from coffee and bread Food Funct 2 2011 117 123
31. J. Shearer, A. Farah, T. de Paulis, D.P. Bracy, R.R. Pencek, and T.E. Graham Quinides of roasted coffee enhance insulin action in conscious rats J Nutr 133 2003 3529 3532
32. A.G. Renehan, D.L. Roberts, and C. Dive Obesity and cancer: pathophysiological and biological mechanisms Arch Physiol Biochem 114 2008 71 83
33. S. Ramos Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways Mol Nutr Food Res 52 2008 507 526
34. R. Viani Composition of coffee S. Garattini, Caffeine, coffee and health 1993 Raven Press New York 17 41
35. T. Ranheim, and B. Halvorsen Coffee consumption and human health - beneficial or detrimental? - Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus Mol Nutr Food Res 49 2005 274 284
36. R. Urgert Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews J Agric Food Chem 43 1995 2167 2172
37. R. Urgert, and M.B. Katan The cholesterol-raising factor from coffee beans Annu Rev Nutr 17 1997 305 324
38. W.W. Huber, G. Scharf, G. Nagel, S. Prustomersky, R. Schulte-Hermann, and B. Kaina Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver - comparison with phase II xenobiotic metabolism Mutat Res 522 2003 57 68
39. W.W. Huber, W. Rossmanith, M. Grusch, E. Haslinger, S. Prustomersky, and B. Peter-Vorosmarty Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver Food Chem Toxicol 46 2008 1230 1238
40. B.J. Majer, E. Hofer, C. Cavin, E. Lhoste, M. Uhl, and H.R. Glatt Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2) Food Chem Toxicol 43 2005 433 441
41. S. Okamura, K. Suzuki, M. Yanase, M. Koizumi, and H.O. Tamura The effects of coffee on conjugation reactions in human colon carcinoma cells Biol Pharm Bull 28 2005 271 274
42. E.A. Vucic, C.J. Brown, and W.L. Lam Epigenetics of cancer progression Pharmacogenomics 9 2008 215 234
43. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Coffee, tea, mate, methylxanthines and methylglyoxal. Lyon, 27 February to 6 March 1990 IARC Monogr Eval Carcinog Risks Hum 51 1991 1 513
44. B.B. Fredholm, K. Battig, J. Holmen, A. Nehlig, and E.E. Zvartau Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 1999 83 133
45. M.B. Silvarola, P. Mazzafera, and L.C. Fazioli A naturally decaffeinated arabic coffee Nature 249 2004 826
46. K. Ramalakshmi, and B. Raghavan Caffeine in coffee: its removal. Why and how? Crit Rev Food Sci Nutr 39 1999 441 456
47. J.J. Barone, and H.R. Roberts Caffeine consumption Food Chem Toxicol 34 1996 119 129
48. H.G. Mandel Update on caffeine consumption, disposition, and action Food Chem Toxicol 40 2002 1231 1234
49. American Institute for Cancer Research. Food, nutrition, physical activity and the prevention of cancer: a global perspective 2007 World Cancer Research Fund/American Institute for Cancer Research
50. T. Zhou, Y. Chen, C. Huang, and G. Chen Caffeine induction of sulfotransferases in rat liver and intestine J Appl Toxicol 2011
51. S.H. Jee, J. He, P.K. Whelton, I. Suh, and M.J. Klag The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials Hypertension 33 1999 647 652
52. M.S. Beaudoin, and T.E. Graham Methylxanthines and human health: epidemiological and experimental evidence Handb Exp Pharmacol 200 2011 509 548
53. A.J. Lee, M.X. Cai, P.E. Thomas, A.H. Conney, and B.T. Zhu Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms Endocrinology 144 2003 3382 3398
54. R.L. Ferrini, and E. Barrett-Connor Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study Am J Epidemiol 144 1996 642 644
55. C. Nagata, M. Kabuto, and H. Shimizu Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women Nutr Cancer 30 1998 21 24
56. J.F. Chen, K. Xu, J.P. Petzer, R. Staal, Y.H. Xu, and M. Beilstein Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease J Neurosci 21 2001 RC143
57. C.F. Brice, and A.P. Smith Factors associated with caffeine consumption Int J Food Sci Nutr 53 2002 55 64
58. S.M. Evans, and R.R. Griffiths Caffeine tolerance and choice in humans Psychopharmacology (Berl) 108 1992 51 59
59. P. Hewlett, and A. Smith Correlates of daily caffeine consumption Appetite 46 2006 97 99
60. H.A. Jones, and C.W. Lejuez Personality correlates of caffeine dependence: the role of sensation seeking, impulsivity, and risk taking Exp Clin Psychopharmacol 13 2005 259 266
61. C.G. Swift, and B. Tiplady The effects of age on the response to caffeine Psychopharmacology (Berl) 94 1988 29 31
62. L.L. Birch Development of food preferences Annu Rev Nutr 19 1999 41 62
63. R.D. Mattes Influences on acceptance of bitter foods and beverages Physiol Behav 56 1994 1229 1236
64. J.X. Guinard, C. Zoumas-Morse, J. Dietz, S. Goldberg, M. Holz, and E. Heck Does consumption of beer, alcohol, and bitter substances affect bitterness perception? Physiol Behav 59 1996 625 631
65. P. Rozin, and T.A. Vollmecke Food likes and dislikes Annu Rev Nutr 6 1986 433 456
66. B.M. Cines, and P. Rozin Some aspects of the liking for hot coffee and coffee flavor Appetite 3 1982 23 34
67. A. Nehlig Are we dependent upon coffee and caffeine? A review on human and animal data Neurosci Biobehav Rev 23 1999 563 576
68. R.R. Griffiths, and J. Mumford Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans C.R. Schuster, M.J. Kuhar, Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach 1996 Springer Verlag Berlin 315 341 Chapter 9
69. H.R. Lieberman, R.J. Wurtman, G.G. Emde, C. Roberts, and I.L. Coviella The effects of low doses of caffeine on human performance and mood Psychopharmacology (Berl) 92 1987 308 312
70. G.B. Kaplan, D.J. Greenblatt, B.L. Ehrenberg, J.E. Goddard, M.M. Cotreau, and J.S. Harmatz Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans J Clin Pharmacol 37 1997 693 703
71. M.M. Lorist, and M. Tops Caffeine, fatigue and cognition Brain Cogn 53 2003 82 94
72. A. Smith Effects of caffeine on human behavior Food Chem Toxicol 40 2002 1243 1255
73. S.M. Evans, and R.R. Griffiths Dose-related caffeine discrimination in normal volunteers: individual differences in subjective and self-reported cues Behav Pharmacol 2 1991 345 356
74. J.W. Daly, and B.B. Fredholm Caffeine - an atypical drug of dependence Drug Alcohol Depend 51 1998 199 206
75. L.M. Juliano, and R.R. Griffiths A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features Psychopharmacology (Berl) 176 2004 1 29
76. R.R. Griffiths, and P.P. Woodson Reinforcing effects of caffeine in humans J Pharmacol Exp Ther 246 1988 21 29
77. S. Soroko, J. Chang, and E. Barrett-Connor Reasons for changing caffeinated coffee consumption: the Rancho Bernardo Study J Am Coll Nutr 15 1996 97 101
78. K.N. Stern, L.D. Chait, and C.E. Johansson Reinforcing and subjective effects of caffeine in normal human volunteers Psychopharmacology (Berl) 98 1989 81 88
79. A. Yang, A.A. Palmer, and H. de Wit Genetics of caffeine consumption and responses to caffeine Psychopharmacology (Berl) 211 3 2010 245 257
80. K.S. Kendler, and C.A. Prescott Caffeine intake, tolerance, and withdrawal in women: a population-based twin study Am J Psychiatry 156 1999 223 228
81. J.M. Hettema, L.A. Corey, and K.S. Kendler A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins Drug Alcohol Depend 57 1999 69 78
82. K.S. Kendler, J. Myers, and C.A. Prescott Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence Arch Gen Psychiatry 64 2007 1313 1320
83. G.E. Swan, D. Carmelli, and L.R. Cardon The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis J Subst Abuse 8 1996 19 31
84. K.S. Kendler, E. Schmitt, S.H. Aggen, and C.A. Prescott Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood Arch Gen Psychiatry 65 2008 674 682
85. V.S. Laitala, J. Kaprio, and K. Silventoinen Genetics of coffee consumption and its stability Addiction 103 2008 2054 2061
86. M. Luciano, K.M. Kirk, A.C. Heath, and N.G. Martin The genetics of tea and coffee drinking and preference for source of caffeine in a large community sample of Australian twins Addiction 100 2005 1510 1517
87. B. Teucher, J. Skinner, P.M. Skidmore, A. Cassidy, S.J. Fairweather-Tait, and L. Hooper Dietary patterns and heritability of food choice in a UK female twin cohort Twin Res Hum Genet 10 2007 734 748
88. J.M. Vink, A.S. Staphorsius, and D.I. Boomsma A genetic analysis of coffee consumption in a sample of Dutch twins Twin Res Hum Genet 12 2009 127 131
89. M. Bonati, R. Latini, F. Galletti, J.F. Young, G. Tognoni, and S. Garattini Caffeine disposition after oral doses Clin Pharmacol Ther 32 1982 98 106
90. N.L. Benowitz Clinical pharmacology of caffeine Annu Rev Med 41 1990 277 288
91. D.J. Birkett, and J.O. Miners Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events Br J Clin Pharmacol 31 1991 405 408
92. A. Lelo, D.J. Birkett, R.A. Robson, and J.O. Miners Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine, and theophylline in man Br J Clin Pharmacol 22 1986 177 182
93. W. Kalow, and B.K. Tang Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking Clin Pharmacol Ther 49 1991 44 48
94. A.D. Kashuba, J.S. Bertino Jr., G.L. Kearns, J.S. Leeder, A.W. James, and R. Gotschall Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping Clin Pharmacol Ther 63 1998 540 551
95. J.L. Ferrero, and A.H. Neims Metabolism of caffeine by mouse liver microsomes: GSH or cytosol causes a shift in products from 1,3,7-trimethylurate to a substituted diaminouracil Life Sci 33 1983 1173 1178
96. R. Latini, M. Bonati, E. Marzi, and S. Garattini Urinary excretion of an uracilic metabolite from caffeine rat, monkey and man Toxicol Lett 7 1981 267 272
97. A. Lelo, J.O. Miners, R. Robson, and D.J. Birkett Quantitative assessment of caffeine partial clearance in man Br J Clin Pharmacol 22 1986 183 186
98. J.O. Miners, and D.J. Birkett The use of caffeine as a metabolic probe for human drug metabolizing enzymes Gen Pharmacol 27 1996 245 249
99. C. Krul, and G. Hageman Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography J Chromatogr B Biomed Sci Appl 709 1998 27 34
100. A. Rostami-Hodjegan, S. Nurminen, P.R. Jackson, and G.T. Tucker Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment Pharmacogenetics 6 1996 121 149
101. A. Gunes, and M.L. Dahl Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms Pharmacogenomics 9 2008 625 637
102. S.F. Zhou, B. Wang, L.P. Yang, and J.P. Liu Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2 Drug Metab Rev 42 2010 268 354
103. F. Berthou, T. Goasduff, Y. Dreano, and J.F. Menez Caffeine increases its own metabolism through cytochrome P4501A induction in rats Life Sci 57 1995 541 549
104. J.A. Swanson, J.W. Lee, and J.W. Hopp Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal Addict Behav 19 1994 229 256
105. Z. Jiang, N. Dragin, L.F. Jorge-Nebert, M.V. Martin, F.P. Guengerich, and E. Aklillu Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype Pharmacogenet Genomics 16 2006 359 367
106. C. Sachse, J. Brockmoller, S. Bauer, and I. Roots Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine Br J Clin Pharmacol 47 1999 445 449
107. R. Ghotbi, M. Christensen, H.K. Roh, M. Ingelman-Sundberg, E. Aklillu, and L. Bertilsson Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans Eur J Clin Pharmacol 63 2007 537 546
108. A. Gunes, G. Ozbey, E.H. Vural, C. Uluoglu, M.G. Scordo, and H. Zengil Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population Pharmacogenomics 10 2009 769 778
109. M.C. Cornelis, A. El-Sohemy, and H. Campos Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption Am J Clin Nutr 86 2007 240 244
110. S. Ferre Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine J Alzheimers Dis 20 Suppl. 1 2010 S35 S49
111. J.W. Daly, P. Butts-Lamb, and W. Padgett Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines Cell Mol Neurobiol 3 1983 69 80
112. J.V. Retey, M. Adam, R. Khatami, U.F. Luhmann, H.H. Jung, and W. Berger A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep Clin Pharmacol Ther 81 2007 692 698
113. K. Alsene, J. Deckert, P. Sand, and H. de Wit Association between A2a receptor gene polymorphisms and caffeine-induced anxiety Neuropsychopharmacology 28 2003 1694 1702
114. E. Childs, C. Hohoff, J. Deckert, K. Xu, J. Badner, and H. de Wit Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety Neuropsychopharmacology 33 2008 2791 2800
115. C. Hohoff, J.M. McDonald, B.T. Baune, E.H. Cook, J. Deckert, and H. de Wit Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants Am J Med Genet B Neuropsychiatr Genet 139B 2005 42 44
116. C. Hohoff, K. Domschke, K. Schwarte, G. Spellmeyer, C. Vogele, and G. Hetzel Sympathetic activity relates to adenosine A(2A) receptor gene variation in blood-injury phobia J Neural Transm 116 2009 659 662
117. J. Deckert, M.M. Nothen, P. Franke, C. Delmo, J. Fritze, and M. Knapp Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease Mol Psychiatry 3 1998 81 85
118. S.P. Hamilton, S.L. Slager, A.B. De Leon, G.A. Heiman, D.F. Klein, and S.E. Hodge Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder Neuropsychopharmacology 29 2004 558 565
119. C. Hohoff, E.L. Mullings, S.V. Heatherley, C.M. Freitag, L.C. Neumann, and K. Domschke Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality J Psychiatr Res 44 2010 930 937
120. K. Yamada, E. Hattori, M. Shimizu, A. Sugaya, H. Shibuya, and T. Yoshikawa Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder J Neural Transm 108 2001 837 848
121. P. Lam, C.J. Hong, and S.J. Tsai Association study of A2a adenosine receptor genetic polymorphism in panic disorder Neurosci Lett 378 2005 98 101
122. D.L. Rosin, A. Robeva, R.L. Woodard, P.G. Guyenet, and J. Linden Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system J Comp Neurol 401 1998 163 186
123. P. Svenningsson, C. Le Moin, G. Fisone, and B.B. Fredholm Distribution, biochemistry and function of striatal adenosine A2a receptors Prog Neurobiol 59 1999 355 396
124. K.L. Gamble, A.A. Motsinger-Reif, A. Hida, H.M. Borsetti, S.V. Servick, and C.M. Ciarleglio Shift work in nurses: contribution of phenotypes and genotypes to adaptation PLoS One 6 2011 e18395
125. J.E. Hayes, M.R. Wallace, V.S. Knopik, D.M. Herbstman, L.M. Bartoshuk, and V.B. Duffy Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults Chem Senses 36 2011 311 319
126. M.G. Ferruzzi The influence of beverage composition on delivery of phenolic compounds from coffee and tea Physiol Behav 100 2010 33 41
127. M.P. Gonthier, M.A. Verny, C. Besson, C. Remesy, and A. Scalbert Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats J Nutr 133 2003 1853 1859
128. J. Bouayed, H. Rammal, A. Dicko, C. Younos, and R. Soulimani Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects J Neurol Sci 262 2007 77 84
129. S. Rosenzweig, W. Yan, M. Dasso, and A.I. Spielman Possible novel mechanism for bitter taste mediated through cGMP J Neurophysiol 81 1999 1661 1665
130. S.J. Moon, M. Kottgen, Y. Jiao, H. Xu, and C. Montell A taste receptor required for the caffeine response in vivo Curr Biol 16 2006 1812 1817
131. M.C. Cornelis, K.L. Monda, K. Yu, N. Paynter, S.N. Bennett, and E. Boerwinkle Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption PLoS Genet 7 4 2011 e1002033
132. P. Sulem, D.F. Gudbjartsson, F. Geller, I. Prokopenko, B. Feenstra, and K.K. Aben Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption Hum Mol Genet 20 2011 2071 2077
133. N. Amin, E. Byrne, J. Johnson, G. Chenevix-Trench, S. Walter, and I.M. Nolte Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM Mol Psychiatry 2012
134. M. Nukaya, and C.A. Bradfield Conserved genomic structure of the Cyp1a1 and Cyp1a2 loci and their dioxin responsive elements cluster Biochem Pharmacol 77 2009 654 659
135. M. Nukaya, S. Moran, and C.A. Bradfield The role of the dioxin-responsive element cluster between the Cyp1a1 and Cyp1a2 loci in aryl hydrocarbon receptor biology Proc Natl Acad Sci USA 106 2009 4923 4928
136. L.F. Jorge-Nebert, Z. Jiang, R. Chakraborty, J. Watson, L. Jin, and S.T. McGarvey Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations Hum Mutat 31 2010 27 40
137. R. Ueda, H. Iketaki, K. Nagata, S. Kimura, F.J. Gonzalez, and K. Kusano A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes Mol Pharmacol 69 2006 1924 1930
138. T. Sakurai, N. Ramoz, J.G. Reichert, T.E. Corwin, L. Kryzak, and C.J. Smith Association analysis of the NrCAM gene in autism and in subsets of families with severe obsessive-compulsive or self-stimulatory behaviors Psychiatr Genet 16 2006 251 257
139. H. Ishiguro, Q.R. Liu, J.P. Gong, F.S. Hall, H. Ujike, and M. Morales NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice Neuropsychopharmacology 31 2006 572 584
140. L.D. Matzel, J. Babiarz, D.A. Townsend, H.C. Grossman, and M. Grumet Neuronal cell adhesion molecule deletion induces a cognitive and behavioral phenotype reflective of impulsivity Genes Brain Behav 7 2008 470 480
141. J. Kotsopoulos, P. Ghadirian, A. El-Sohemy, H.T. Lynch, C. Snyder, and M. Daly The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers Cancer Epidemiol Biomarkers Prev 16 2007 912 916
142. E. Bageman, C. Ingvar, C. Rose, and H. Jernstrom Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status Cancer Epidemiol Biomarkers Prev 17 2008 895 901
143. S. Rabstein, T. Bruning, V. Harth, H.P. Fischer, S. Haas, and T. Weiss N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer Eur J Cancer Prev 19 2010 100 109
144. M.T. Goodman, K.H. Tung, K. McDuffie, L.R. Wilkens, and T.A. Donlon Association of caffeine intake and CYP1A2 genotype with ovarian cancer Nutr Cancer 46 2003 23 29
145. K.L. Terry, L. Titus-Ernstoff, E.O. Garner, A.F. Vitonis, and D.W. Cramer Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk Cancer Epidemiol Biomarkers Prev 12 2003 187 190
146. J. Kotsopoulos, A.F. Vitonis, K.L. Terry, I. De Vivo, D.W. Cramer, and S.E. Hankinson Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer Cancer Causes Control 20 2009 335 344
147. M.L. Slattery, E. Kampman, W. Samowitz, B.J. Caan, and J.D. Potter Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer Int J Cancer 87 2000 728 733
148. L. Covolo, D. Placidi, U. Gelatti, A. Carta, A. Scotto Di Carlo, and P. Lodetti Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study Eur J Epidemiol 23 2008 355 362
149. C.M. Villanueva, D.T. Silverman, C. Murta-Nascimento, N. Malats, M. Garcia-Closas, and F. Castro Coffee consumption, genetic susceptibility and bladder cancer risk Cancer Causes Control 20 2009 121 127
150. S. Pavanello, G. Mastrangelo, D. Placidi, M. Campagna, A. Pulliero, and A. Carta CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer Eur J Epidemiol 25 2010 491 500
151. J. Clavel, S. Bellec, S. Rebouissou, F. Menegaux, J. Feunteun, and C. Bonaiti-Pellie Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy Eur J Cancer Prev 14 2005 531 540
152. P. Happonen, S. Voutilainen, T.P. Tuomainen, and J.T. Salonen Catechol-o-methyltransferase gene polymorphism modifies the effect of coffee intake on incidence of acute coronary events PLoS One 1 2006 e117
153. M.C. Cornelis, A. El-Sohemy, E.K. Kabagambe, and H. Campos Coffee, CYP1A2 genotype, and risk of myocardial infarction JAMA 295 2006 1135 1141
154. P. Palatini, G. Ceolotto, F. Ragazzo, F. Dorigatti, F. Saladini, and I. Papparella CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension J Hypertens 27 2009 1594 1601
155. B.H. Bech, H. Autrup, E.A. Nohr, T.B. Henriksen, and J. Olsen Stillbirth and slow metabolizers of caffeine: comparison by genotypes Int J Epidemiol 35 2006 948 953
156. P.L. Zusterzeel, W.L. Nelen, H.M. Roelofs, W.H. Peters, H.J. Blom, and E.A. Steegers Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss Mol Hum Reprod 6 2000 474 478
157. F. Sata, H. Yamada, K. Suzuki, Y. Saijo, E.H. Kato, and M. Morikawa Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss Mol Hum Reprod 11 2005 357 360
158. C. Infante-Rivard Caffeine intake and small-for-gestational-age birth: modifying effects of xenobiotic-metabolising genes and smoking Paediatr Perinat Epidemiol 21 2007 300 309
159. R.J. Schmidt, P.A. Romitti, T.L. Burns, J.C. Murray, M.L. Browne, and C.M. Druschel Caffeine, selected metabolic gene variants, and risk for neural tube defects Birth Defects Res A Clin Mol Teratol 88 2010 560 569
160. T. Nonaka, K. Takakuwa, and K. Tanaka Analysis of the polymorphisms of genes coding biotransformation enzymes in recurrent miscarriage in the Japanese population J Obstet Gynaecol Res 37 2011 1352 1358
161. K.C. Taylor, C.M. Small, C.E. Dominguez, L.E. Murray, W. Tang, and M.M. Wilson Alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2 Ann Epidemiol 21 2011 864 872
162. E.K. Tan, E. Chua, S.M. Fook-Chong, Y.Y. Teo, Y. Yuen, and L. Tan Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers Pharmacogenet Genomics 17 2007 1001 1005
163. E.K. Tan, Z.Y. Lu, S.M. Fook-Chong, E. Tan, H. Shen, and E. Chua Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease Am J Med Genet B Neuropsychiatr Genet 141B 2006 634 636
164. M.F. Facheris, N.K. Schneider, T.G. Lesnick, M. de Andrade, J.M. Cunningham, and W.A. Rocca Coffee, caffeine-related genes, and Parkinson's disease: a case-control study Mov Disord 23 2008 2033 2040
165. N. Palacios, M. Weisskopf, K. Simon, X. Gao, M. Schwarzschild, and A. Ascherio Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women Parkinsonism Relat Disord 16 2010 370 375
166. R.A. Popat, S.K. Van Den Eeden, C.M. Tanner, F. Kamel, D.M. Umbach, and K. Marder Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease Eur J Neurol 18 2011 756 765
167. E.M. Hill-Burns, T.H. Hamza, C.P. Zabetian, S.A. Factor, and H. Payami An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease Eur J Neurol 18 2011 e107 e108
168. T. Hamza, H. Chen, E. Hill-Burns, S. Rhodes, and J.S. Montimurro Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee PLoS Genet 7 2011 e1002237
169. C.C. McCulloch, D.M. Kay, S.A. Factor, A. Samii, J.G. Nutt, and D.S. Higgins Exploring gene-environment interactions in Parkinson's disease Hum Genet 123 2008 257 265
170. D.B. Hancock, E.R. Martin, J.M. Vance, and W.K. Scott Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease Neurogenetics 9 2008 249 262
171. A. Kokaze, M. Ishikawa, N. Matsunaga, K. Karita, M. Yoshida, and T. Ohtsu NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modulates the effects of coffee consumption on the risk of hypertension in middle-aged Japanese men J Epidemiol 19 2009 231 236
172. X. Yu, Z. Bao, J. Zou, and J. Dong Coffee consumption and risk of cancers: a meta-analysis of cohort studies BMC Cancer 11 2011 96
173. J.D. Peck, A. Leviton, and L.D. Cowan A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000-2009 update Food Chem Toxicol 48 2010 2549 2576
174. A. Leviton, and L. Cowan A review of the literature relating caffeine consumption by women to their risk of reproductive hazards Food Chem Toxicol 40 2002 1271 1310
175. J. Costa, N. Lunet, C. Santos, J. Santos, and A. Vaz-Carneiro Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies J Alzheimers Dis 20 Suppl. 1 2010 S221 S238
176. J.F. Chen, and Y. Chern Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies Handb Exp Pharmacol 200 2011 267 310
177. T. Coleman, S.W. Ellis, I.J. Martin, M.S. Lennard, and G.T. Tucker 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4 - implications for susceptibility to Parkinson's disease J Pharmacol Exp Ther 277 1996 685 690
178. M. Noordzij, C.S. Uiterwaal, L.R. Arends, F.J. Kok, D.E. Grobbee, and J.M. Geleijnse Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized trials J Hypertens 23 2005 921 928
179. M.G. Myers, and A. Basinski Coffee and coronary heart disease Arch Intern Med 152 1992 1767 1772
180. S. Greenland A meta-analysis of coffee, myocardial infarction, and coronary death Epidemiology 4 1993 366 374
181. I. Kawachi, G.A. Colditz, and C.B. Stone Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis Br Heart J 72 1994 269 275
182. F. Sofi, A.A. Conti, A.M. Gori, M.L. Eliana Luisi, A. Casini, and R. Abbate Coffee consumption and risk of coronary heart disease: a meta-analysis Nutr Metab Cardiovasc Dis 17 2007 209 223
183. M.C. Cornelis, and A. El-Sohemy Coffee, caffeine, and coronary heart disease Curr Opin Clin Nutr Metab Care 10 2007 745 751
184. J. Abraham, J.O. Mudd, N.K. Kapur, K. Klein, H.C. Champion, and I.S. Wittstein Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists J Am Coll Cardiol 53 2009 1320 1325
185. G. Fisone, A. Borgkvist, and A. Usiello Caffeine as a psychomotor stimulant: mechanism of action Cell Mol Life Sci 61 2004 857 872
186. S. Ferre An update on the mechanisms of the psychostimulant effects of caffeine J Neurochem 105 2008 1067 1079
187. L. Sreerama, M.W. Hedge, and N.E. Sladek Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli Clin Cancer Res 1 1995 1153 1163
188. Y. Fukushima, M. Kasuga, K. Nakao, I. Shimomura, and Y. Matsuzawa Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets J Agric Food Chem 57 2009 11100 11105
189. A.H. Stonehouse, M. Adachi, E.C. Walcott, and F.S. Jones Caffeine regulates neuronal expression of the dopamine 2 receptor gene Mol Pharmacol 64 2003 1463 1473
190. S. Connolly, and T.J. Kingsbury Caffeine modulates CREB-dependent gene expression in developing cortical neurons Biochem Biophys Res Commun 397 2010 152 156
191. L.K. Lam, V.L. Sparnins, and L.W. Wattenberg Isolation and identification of kahweol palmitate and cafestol palmitate as active constituents of green coffee beans that enhance glutathione S-transferase activity in the mouse Cancer Res 42 1982 1193 1198
192. C. Cavin, D. Holzhauser, A. Constable, A.C. Huggett, and B. Schilter The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism Carcinogenesis 19 1998 1369 1375